Total Health's 2024 Community Oncology Educational Discussion Series (COEDS) consists of educational activities designed to meet the educational needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of breast cancer. The agenda is comprised of multidisciplinary, case-based presentations that break down the most clinically relevant information applicable to community care. This accredited meeting is hosted as an in-person conference only.
Meeting registrations will require a credit card as a cancellation hold. A fee of $25 will only be incurred in the event of a no-show or cancellation within 14 days without written confirmation to the Total Health Program Team.
1901 N Military Trl
Boca Raton, FL 33431
Accreditation Information | 1.25
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.25 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 1.25 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
Employ an understanding of personalized medicine to individualize the use of available drugs for breast cancers.
Communicate the efficacy and safety of the drugs discussed in the case studies and other emerging treatments for breast cancers.
Understand the emerging and standard diagnostic tests used to assist in planning therapy for breast cancers.
Formulate management strategies, considering the contributory roles of local and systemic therapy.
Recall the design of ongoing clinical trials evaluating novel investigational agents and counsel appropriately selected patients about availability and participation.
What to Expect
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program